You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Artificial tears

Showing 1 - 25 of 2,743
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Nasolacrimal Duct Obstruction, Thyroid Cancer Trial (Artificial Tears Methylcellulose)

Not yet recruiting
  • Nasolacrimal Duct Obstruction
  • Thyroid Cancer
  • Artificial Tears Methylcellulose
  • (no location specified)
Aug 17, 2023

Thyroid Carcinoma, Radioactive Iodine Level Trial in Nashville (Artificial Tears)

Recruiting
  • Thyroid Carcinoma
  • Radioactive Iodine Level
  • Artificial Tears
  • Nashville, Tennessee
    Vanderbilt University Medical Center
Jan 25, 2023

Dry Eye Syndromes Trial in Gainesville (Carboxymethylcellulose (CMC) Artificial Tears, Preservative-free, CMC-free Artificial

Completed
  • Dry Eye Syndromes
  • Carboxymethylcellulose (CMC) Artificial Tears
  • Preservative-free, CMC-free Artificial Tears (control)
  • Gainesville, Florida
    University of Florida Oaks Eye Center
Jul 21, 2022

Dry Eye Trial in Berkeley (Systane Complete PF, Refresh Relieva PF, Refresh Optive Mega-3 PF)

Not yet recruiting
  • Dry Eye
  • Systane Complete PF
  • +3 more
  • Berkeley, California
    Clinical Research Center, School of Optometry, University of Cal
Jan 20, 2023

Contact Lens Complication Trial in Valladolid (Aquoral Lipo (Esteve), Hyabak (Thea))

Recruiting
  • Contact Lens Complication
  • Aquoral Lipo (Esteve)
  • Hyabak (Thea)
  • Valladolid, Spain
    IOBA - University of Valladolid
Nov 28, 2022

Diabetic Retinopathy With Macular Edema of Both Eyes (Diagnosis), Central Retinal Vein Occlusion With Macular Edema, Exudative

Completed
  • Diabetic Retinopathy With Macular Edema of Both Eyes (Diagnosis)
  • +6 more
  • Refresh Plus Preservative-free Lubricant Eye Drops
  • Iowa City, Iowa
    University of Iowa Hospitals & Clinics - Department of Ophthalmo
Apr 16, 2023

Pain, Intravitreal Injection, Pain, Acute Trial in Canada, United States (Use of bromfenac 0.09% to reduce intravitreal

Recruiting
  • Pain
  • +2 more
  • Use of bromfenac 0.09% to reduce intravitreal injection pain
  • Use of artificial tears to reduce intravitreal injection pain
  • Boston, Massachusetts
  • +4 more
Nov 8, 2023

Dry Eye Disease Trial in Oslo (Thealoz Duo (combination of trehalose and hyaluronate) eye drop and Hyabak (hyaluronate) eye

Recruiting
  • Dry Eye Disease
  • Thealoz Duo (combination of trehalose and hyaluronate) eye drop and Hyabak (hyaluronate) eye drop
  • Oslo, Norway
    The Norwegian Dry Eye Clinic
Jun 27, 2022

Dry Eye Trial in Shenyang (Diquafosol tetrasodium, Heated eye mask)

Not yet recruiting
  • Dry Eye
  • Diquafosol tetrasodium
  • Heated eye mask
  • Shenyang, Liaoning, China
    He Eye Hospital
Jan 31, 2023

Dry Eye, Insulin Trial in Madrid (Insulin, Cyclosporins, Artificial tears)

Recruiting
  • Dry Eye
  • Insulin
  • Madrid, Spain
    Hospital Clinico San Carlos
Jan 18, 2023

Open Angle Glaucoma Trial (NCX 470, Placebo)

Not yet recruiting
  • Open Angle Glaucoma
  • NCX 470
  • Placebo
  • (no location specified)
Jul 6, 2023

Diabetic Eye Problems Trial in Shenyang (3% Diquafosol tetrasodium, 0.1% hyaluronate)

Not yet recruiting
  • Diabetic Eye Problems
  • 3% Diquafosol tetrasodium
  • 0.1% hyaluronate
  • Shenyang, Liaoning, China
    He Eye Hospital
Jan 10, 2023

Age-Related Macular Degeneration Trial (Loteprednol Etabonate Ophthalmic Gel [Lotemax], Nepafenac Ophthalmic 0.3% Ophthalmic

Not yet recruiting
  • Age-Related Macular Degeneration
  • Loteprednol Etabonate Ophthalmic Gel [Lotemax]
  • +2 more
  • (no location specified)
Sep 14, 2022

Dry Eye Syndromes Trial in Racine (Dextenza 0.4Mg Intracanalicular Insert, Over the counter Artificial tears)

Completed
  • Dry Eye Syndromes
  • Dextenza 0.4Mg Intracanalicular Insert
  • Over the counter Artificial tears
  • Racine, Wisconsin
    The Eye Center of Racine
Apr 21, 2022

Dry Eye Syndromes Trial in Kowloon, Shatin (TCM ultrasonic atomization treatment with herbal Compound Decoction (CD), TCM

Not yet recruiting
  • Dry Eye Syndromes
  • TCM ultrasonic atomization treatment with herbal Compound Decoction (CD)
  • +4 more
  • Kowloon, Hong Kong
  • +3 more
Oct 13, 2023

Cataract Trial in New York (Systane Complete)

Withdrawn
  • Cataract
  • Systane Complete
  • New York, New York
    Weill Cornell Ophthalmology
Jun 16, 2021

Dry Eye Trial in Pittsburgh (Cyclosporine, Artificial tear)

Not yet recruiting
  • Dry Eye
  • Pittsburgh, Pennsylvania
    UPMC Eye Center
Jan 5, 2022

Microbiota, Ocular Surface Trial in Leuven (Conjunctival swab, Oxybuprocaine Hydrochloride 0.4% Eye Drops, artificial tears)

Completed
  • Microbiota
  • Ocular Surface
  • Conjunctival swab
  • +2 more
  • Leuven, Belgium
    University Hospitals Leuven, Department of Ophthalmology
Jul 18, 2022

Dry Eye Disease Trial in Boston (Lotemax, Soothe Tired Eyes Lubricant Eye Drop (Artificial Tears), In Vivo Confocal Microscopy

Completed
Has Results
  • Dry Eye Disease
  • Boston, Massachusetts
    Tufts Medical Center
Feb 24, 2022

Rhegmatogenous Retinal Detachment, Proliferative Vitreoretinopathy Trial in Philadelphia (Netarsudil 0.02% Ophthalmic Solution

Not yet recruiting
  • Rhegmatogenous Retinal Detachment
  • Proliferative Vitreoretinopathy
  • Netarsudil 0.02% Ophthalmic Solution [RHOPRESSA]
  • Glycerin 0.2%/Hypromellose 0.2%/Peg 1%/Soln,Oph,Ud
  • Philadelphia, Pennsylvania
    Wills Eye Physicians - Mid Atlantic Retina
Dec 13, 2022

Trachomatous Trichiasis (TT), Eye Diseases, Eyelid Diseases Trial in Addis Ababa (Fluorometholone 0.1% Oph Susp, Artificial

Recruiting
  • Trachomatous Trichiasis (TT)
  • +4 more
  • Fluorometholone 0.1% Oph Susp
  • Artificial Tears
  • Addis Ababa, Ethiopia
    Ministry of Science and Higher Education Ethiopia
Jun 24, 2022

Diabetic Retinopathy Trial in Nashville (Ketorolac 0.45% ophthalmic solution, Placebo - Preservative-free artificial tears,

Recruiting
  • Diabetic Retinopathy
  • Ketorolac 0.45% ophthalmic solution
  • +2 more
  • Nashville, Tennessee
    Vanderbilt University Medical Center
Feb 16, 2022

Diabetic Macular Edema Trial in Tehran (Injections of 1.25 mg of intravitreal bevacizumab with Timolol and Dorzolamide,

Active, not recruiting
  • Diabetic Macular Edema
  • Injections of 1.25 mg of intravitreal bevacizumab with Timolol and Dorzolamide
  • Injections of 1.25 mg of intravitreal bevacizumab with artificial tears
  • Tehran, Iran, Islamic Republic of
    Ophthalmic Research Center
Oct 6, 2021

Keratitis, Corneal Ulcer Trial in United States (PXL Platinum 330 system + Riboflavin 0.25% TE Solution, Sham CXL + Artificial

Recruiting
  • Keratitis
  • Corneal Ulcer
  • PXL Platinum 330 system + Riboflavin 0.25% TE Solution
  • Sham CXL + Artificial Tears
  • Tampa, Florida
  • +7 more
Jul 13, 2022

Diabetic Eye Problems Trial in Shenyang (3% Diquafosol tetrasodium, 0.1% hyaluronate)

Completed
  • Diabetic Eye Problems
  • 3% Diquafosol tetrasodium
  • 0.1% hyaluronate
  • Shenyang, Liaoning, China
    He Eye Hospital
Sep 6, 2021